Synergy Member Testimonial: A Journey with Pain Management over the years!

Hello, my name is Sarah Gould-Biggs.

I am 40 years old, and at 18, I was in a tragic accident. For many, many years afterwards, I had surgery after surgery, with dozens of medications.

To this day, I have chronic injuries and pain because of them, yet I try to lead an active life.

I began with the tinctures and did them for about one year. However, because of digestive issues and reflux, I was unable to continue, so I switched to the suppositories. They were quite relieving at first and worked well for pain for two years. Then, I felt my body build a tolerance to them, as with many other things. I stopped for four or five months, then my pain became unmanageable again.

I restarted them just a couple nights a week and felt relief. With the guidance of Leonard, I have started a new protocol, and will hopefully find daily relief again.

I cannot thank Synergy Wellness & Healing Essence, Leonard, and the rest of the team that has helped me the last few years.

All the praise, love, and light.

Sarah Gould-Biggs

July, 2023

Cannabinoids Galore!

Our cannabis knowledge is increasing exponentially thanks to scientific enquiry and we are constantly learning more about the potential health benefits of cannabinoids.

So far, over a hundred cannabinoids have been identified in the cannabis plant and research is underway to discover the attributes of many of these unique compounds. Current studies show particular interest in CBV, CBC and THCV.

Cannabinoids derived from cannabis are phytocannabinoids, meaning from plants, incredibly they match the endocannabinoids that exist in all mammals and play a central role in maintaining health.

Medical science now acknowledges that auto-immune conditions are linked to deficiencies in the endo-cannabinoid system (ECS) and that an emphasis on a healthy ECS brings wide-reaching health benefits. Well documented successful treatment of epilepsy, digestive disorders, arthritis, anxiety and depression and cancer are driving more research.

Currently it’s open season for scientific cannabinoid studies and new research is revealing other plants which contain significant phytocannabinoids.

We are living through a paradoxical moment in cannabinoid awareness: On the one hand, scientific research shows how cannabinoids support our ECS ( Endocannabinoid system) which functions to maintain balance in the body, on the other hand, cannabis, the main source of phytocannabinoids remains illegal in many countries. The legal issues of cannabis stem from the presence of THC, the only psychotropic cannabinoid that has been discovered.

This has led to the extraction of cannabinoids, most notably CBD, from industrial hemp, which contains less than 0.3% THC. Hemp doesn’t contain the same level of cannabinoids as cannabis so hemp-derived CBD means vast amounts of hemp are needed to meet demand.

Science has revealed that small amounts of cannabinoids occur in a wide range of plants; chocolate, black pepper and liverwort are just three examples. Though these sources are not viable for extraction, other plants are yielding some astonishing results.

A recent study by a team led by molecular biologist Rodrigo Moura Neto of the Federal University of Rio de Janeiro, has discovered that a common weed that grows all over Brazil contains large amounts of CBD, but no THC.

Trema Micrantha Blume is a prolific shrub, native to South America and growing wild all over the sub-continent. Neto’s research team found high levels of CBD in the plant and have been awarded a research grant from the Brazilian government to continue their work. Neto is excited about the possibility of a viable source of CBD which sidesteps the illegality of cannabis in Brazil.

The CBD market alone is a 5 billion dollar industry worldwide and is predicted to reach 47 billion dollars by 2028, fuelled by high demand from the health and wellness industry.

The discovery of CBD-rich Trema Micrantha Blume holds promise for the future, potentially providing medicine and an economic boost for South America. Who knows where we’ll find cannabinoids next?